COMMUNIQUÉS West-GlobeNewswire
-
Rad Source Launches AccuTag™ Blood Irradiation Indicators Ahead of AABB 2026
14/10/2026 -
SAB BIO to Participate in Chardan 10th Annual Healthcare Conference
14/10/2026 -
Prodeon Medical Announces First Commercial Case of the Urocross® Expander System
14/10/2026 -
Propanc Biopharma Announces Publication of Pilot Study Demonstrating Potent Anti-Tumor Efficacy of PRP Pancreatic Proenzyme Formulation in Pancreatic & Ovarian Cancer
14/10/2026 -
Ultragenyx Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $203 Million
14/10/2026 -
Le Forum en médecine familiale, le plus grand rassemblement de médecins de famille au Canada, revient à Toronto en novembre!
14/10/2026 -
Family Medicine Forum, Canada’s largest family medicine celebration, returns to Toronto this November
14/10/2026 -
SeaStar Medical Chief Medical Officer Kevin Chung, MD, Named 2026 Recipient of the Combat Nephrology Award
14/10/2026 -
Cannabix Technologies Files Provisional Patent Application for BCU-Enabled Point-of-Care Marijuana Breath Testing
14/10/2026 -
INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer’s Drug Research and Explore New Applications for XPro ™
14/10/2026 -
Parexel to Spotlight Site Partnership, Innovation & Industry-Leading Site Performance at 2026 Society for Clinical Research Sites (SCRS) Global Site Solutions Summit™
14/10/2026 -
Editas Medicine Announces Poster Presentations at the European Society of Gene and Cell Therapy (ESGCT) 33rd Annual Congress and Participation in Upcoming Investor Conference
14/10/2026 -
Imprivata’s Access Intelligence Platform Wins Cybersecurity Breakthrough Award for Second Consecutive Year
14/10/2026 -
Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System
14/10/2026 -
Femasys Doubles Enrolling Sites in FemBloc FINALE Pivotal Trial for Non-Surgical Permanent Birth Control
14/10/2026 -
Dongsung Chemical and CJ Biomaterials Introduce First PHA-Based ECOVIVA® Hotmelt Adhesive Available in the US Market
14/10/2026 -
Three-Year Real-World Study Compares Burosumab Treatment with Oral Phosphate and Active Vitamin D in Adults with XLH
14/10/2026 -
Oncolytics Biotech® Provides Update on GOBLET Study Clinical Data and Final PanCAN Grant Payment
14/10/2026 -
MindBio Completes Manufacture of Next-Generation Voice AI Intoxication Detection Kiosk. Advances Software Validation & Testing Towards In Preparation for First Commercial Pilot.
14/10/2026
Pages